• Balsalazide and Prodrug Strategies in Ulcerative Colitis The

  2026-05-15

  This article reviews the pivotal study on balsalazide, a 5-aminosalicylate prodrug developed for active ulcerative colitis. By analyzing its design, mechanisms, and clinical findings, we highlight implications for anti-inflammatory compound development and future research in immune pathway modulation.

• Evaluating Fumagillin’s Efficacy Against Azumiobodo hoyamush

  2026-05-15

  This study systematically assessed the in vitro and in vivo efficacy of 20 antiprotozoal agents—including Fumagillin—against Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings highlight moderate potency of Fumagillin and delineate practical strategies for parasite control in aquaculture, with implications for both parasitology and broader research into methionine aminopeptidase-2 inhibition.

• Cy5.5 NHS Ester: Precision Biomolecule Labeling for In Vivo

  2026-05-14

  Cy5.5 NHS ester (non-sulfonated) empowers researchers to achieve highly sensitive, stable, and site-specific labeling of proteins and nucleic acids for deep-tissue optical imaging. This workflow-driven guide reveals how to maximize labeling efficiency, troubleshoot common pitfalls, and leverage APExBIO’s robust dye for advanced in vivo and nanoplatform applications.

• Chlorambucil: Advanced Insights into DNA Crosslinking and Se

  2026-05-14

  Explore the scientific mechanisms and assay implications of Chlorambucil, a nitrogen mustard alkylating agent, with an in-depth analysis of its DNA crosslinking and selective cytotoxicity. This article delivers a unique, evidence-based perspective for researchers seeking to optimize cancer drug response studies.

• PBS Liposomes: Mechanistic Controls for Translational Immuno

  2026-05-13

  This article provides a thought-leadership perspective on the mechanistic underpinnings and translational value of PBS Liposomes as control reagents in macrophage depletion research. Integrating recent ion channel structural insights and referencing the evolving landscape of immunological assay controls, we outline best practices for protocol design, competitive benchmarking, and future directions in translational medicine.

• miR-196a Drives Esophageal Adenocarcinoma via the c-Myc/TERT

  2026-05-13

  This study reveals how overexpression of microRNA-196a (miR-196a) enhances aggressiveness in esophageal adenocarcinoma (EAC) by activating the c-Myc/TERT/NFκB molecular axis. Targeting this pathway offers new avenues for understanding EAC progression and for developing mechanistically informed cancer research workflows.

• D-N-Acetylgalactosamine: Technical Guide for Glycoprotein Re

  2026-05-12

  D-N-Acetylgalactosamine provides a high-purity, water-soluble standard for analyzing glycoprotein structure and glycosylation pathways in neurological research. It is not suitable for workflows requiring ethanol solubility or long-term storage of prepared solutions. Strict adherence to product-specific handling and protocol recommendations ensures reliable and reproducible results.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-05-12

  This study reveals that the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) via different molecular pathways. These findings clarify the mechanistic roles of the TLR2/ERK and JNK/ERK signaling axes in fungal mastitis and offer new directions for molecular research and intervention.

• AG-221 (Enasidenib): Intervening in Metabolic Vulnerabilitie

  2026-05-11

  Explore AG-221 (Enasidenib) as a potent IDH2 inhibitor for acute myeloid leukemia research. This article reveals how targeting metabolic rewiring—beyond simple 2-hydroxyglutarate reduction—unlocks new strategies for overcoming resistance in IDH2-mutant hematologic malignancies.

• Açaí Extracts: Cytotoxicity and Enzyme Induction in Hepatocy

  2026-05-11

  This study systematically investigates the cytotoxic and pharmacokinetic effects of açaí (Euterpe oleracea) extracts in human hepatocytes. By employing diverse extract preparations and rigorous in vitro modeling, the paper clarifies the limited potential for açaí-induced modulation of major drug-metabolizing enzymes and transporters, offering key insights for botanical-drug interaction risk assessment.

• Cefotaxime in Antimicrobial Resistance Models: Protocols & P

  2026-05-10

  Cefotaxime, a third-generation cephalosporin antibiotic, is a mainstay for dissecting antimicrobial resistance and modeling Gram-positive and Gram-negative infections. This article delivers protocol enhancements, troubleshooting tactics, and practical insights—bridging epidemiological breakthroughs to bench-ready workflows.

• ARCA EGFP mRNA (5-moUTP): Redefining Reporter Assay Excellen

  2026-05-09

  Explore how ARCA EGFP mRNA (5-moUTP) sets a new standard for fluorescence-based mRNA transfection in mammalian cells. This article blends deep mechanistic insight with strategic, evidence-driven guidance—empowering translational researchers to maximize data integrity, immune-silence, and assay reproducibility.

• Macrophage EP4 Loss Promotes Atherosclerosis via CD36 Pathwa

  2026-05-08

  This study reveals that macrophage-specific EP4 deficiency accelerates atherosclerosis by upregulating CD36-mediated lipid uptake and promoting M1 macrophage polarization. The findings clarify the mechanistic role of EP4 in plaque progression and highlight CD36 as a potential therapeutic target in cardiovascular disease.

• Metabolomics Reveals Resistance Mechanisms in CPE via LC-MS/

  2026-05-08

  This article examines how Dixon et al. (2025) leveraged LC-MS/MS metabolomics to rapidly differentiate carbapenemase-producing Enterobacterales (CPE) from non-CPE strains. The study's identification of metabolite biomarkers advances rapid diagnostics for antimicrobial resistance, with practical implications for research on carbapenem antibiotic efficacy and resistance phenotyping.

• ETS1-SENP2 Axis Regulates Mitophagy in Bronchopulmonary Dysp

  2026-05-07

  This study identifies ETS1 as a novel regulator that mitigates mitochondrial damage-induced autophagy in bronchopulmonary dysplasia (BPD) through the SENP2/HSPA8/FUNDC1 axis. By elucidating the mechanism of sumoylation inhibition in mitophagy, the work provides a molecular basis for targeted strategies in BPD management.

15973 records 1/1065 page Next 12345 下5页 Last page